Cynvenio Biosystems
Westlake Village, US · Founded 2009 · Delaware corporation · 1 known investors
Founders & leadership
Cynvenio Biosystems was founded in 2009 by Tom Hyongsok Soh.
TH
Tom Hyongsok SohFounder
AD
Andre de FuscoChief Executive Officer
MP
Michael PfauSecretary
Board
AM
Amit MunshiBoard director
PB
Paul BillingsBoard director
FG
Frederick GluckBoard director
YP
YuCai Peng, Ph.DBoard director
DF
Daotian Fu, Ph.DBoard director
AH
Alan HeegerBoard director
SR
Simon RaabBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$50.6M disclosed across 9 rounds · 2013–2024
▶$315.8KraisedMar 2024 · 8 investors · BiotechnologyRule 506(b)
▶$315.8KraisedMar 2024 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sara BarringtonDirector
- Andrew BotelerDirector
- James McCulloughDirector
- Paul PaganoExecutive Officer, Director
- David AndersonExecutive Officer, Director
- Roy DavisDirector
- Offering amount
- $315.8K
- Amount sold
- $315.8K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedJul 2021 · 2 investors · BiotechnologyRule 506(b)
▶$1.1MraisedJul 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sara BarringtonDirector
- Paul PaganoExecutive Officer, Director
- Andrew BotelerDirector
- Gordon Roy DavisDirector
- David AndersonExecutive Officer, Director
- James McCulloughDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.1MraisedJul 2021 · 1 investors · BiotechnologyRule 506(b)
▶$6.1MraisedJul 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David AndersonExecutive Officer, Director
- Gordon Roy DavisDirector
- James McCulloughDirector
- Andrew BotelerDirector
- Paul PaganoExecutive Officer, Director
- Sara BarringtonDirector
- Offering amount
- $6.1M
- Amount sold
- $6.1M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.8MraisedJul 2021 · 2 investors · BiotechnologyRule 506(b)
▶$2.8MraisedJul 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul AndersonExecutive Officer, Director
- James McCulloughDirector
- Sara BarringtonDirector
- Paul PaganoExecutive Officer, Director
- Gordon Roy DavisDirector
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.2MraisedMay 2021 · 35 investors · OtherRule 506(b)
▶$10.2MraisedMay 2021 · 35 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James McCulloughDirector
- David AndersonExecutive Officer
- Paul PaganoExecutive Officer, Director
- Simon RaabDirector
- Frederick GluckDirector
- Jianing LiuDirector
- Michael PfauExecutive Officer
- Justin XiangDirector
- Offering amount
- $12.3M
- Amount sold
- $10.2M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$90KraisedDec 2020 · 1 investors · OtherRule 506(b)
▶$90KraisedDec 2020 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Paul PaganoExecutive Officer, Director
- Justin XiangDirector
- Simon RaabDirector
- Jianing LiuDirector
- Frederick GluckDirector
- David AndersonExecutive Officer
- Michael PfauExecutive Officer
- James McCulloughDirector
- Dennis StubblefieldDirector
- Jeffrey KobDirector
- Offering amount
- $90K
- Amount sold
- $90K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25.4MraisedJun 2015 · 41 investors · OtherRule 506(c)
▶$25.4MraisedJun 2015 · 41 investors · Other
Rule 506(c)Officers, directors & promoters on the filing
- Paul BillingsDirector
- Andre de FuscoExecutive Officer, Director
- Frederick GluckDirector
- YuCai Peng, Ph.DDirector
- Michael PfauExecutive Officer
- Daotian Fu, Ph.DDirector
- Alan HeegerDirector
- Simon RaabDirector
- Offering amount
- $25.4M
- Amount sold
- $25.4M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$3MraisedSep 2014 · 23 investors · OtherRule 506(b)
▶$3MraisedSep 2014 · 23 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tom Hyongsok SohDirector
- Alan HeegerDirector
- Michael PfauExecutive Officer
- Andre De FuscoExecutive Officer, Director
- Simon RaabDirector
- Frederick GluckDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Cynvenio Biosystems?
- Cynvenio Biosystems was founded by Tom Hyongsok Soh in 2009.
- Who are Cynvenio Biosystems's investors?
- Cynvenio Biosystems's investors include Syno Capital, LLC.
- How much funding has Cynvenio Biosystems raised?
- Cynvenio Biosystems has disclosed $50.6M raised across 9 rounds.
- Where is Cynvenio Biosystems headquartered?
- Cynvenio Biosystems is headquartered in Westlake Village, US.